CHICAGO — The numbers tell a grim story. In mice with lung tumors carrying a specific genetic flaw, a high-fat diet did not help. It made things worse.
Sharply worse. Researchers at an undisclosed institution tracked the effects of a high-fat, high-calorie diet on mice with lung tumors bearing mutations in the Lkb1 gene.
The diet was intended to rescue the animals from cachexia — the severe wasting syndrome that afflicts many cancer patients. It backfired. Food intake dropped.
Water intake dropped. Physical activity dropped.
Mortality accelerated. And none of this occurred because the tumors grew larger. The diet itself, combined with the tumor genetics, drove the decline.
Cachexia has no effective treatment. It causes involuntary weight loss, muscle wasting, and reduced appetite. It worsens quality of life.
It limits tolerance to cancer therapy. It cuts survival short.
The numbers from this mouse study, published July 2, suggest a previously unknown mechanism. The key figure is prostaglandin E2. This inflammatory molecule sits at the center of the newly discovered pathway.
Michael Cross and his team found that when mice with Lkb1-mutant lung tumors ate the high-fat diet, prostaglandin E2 signaling ramped up. That signaling connected the tumor genetics, the diet, and the nervous system.
The result was catastrophic. The mice stopped eating. They stopped drinking.
They stopped moving. They died faster. But the study tested more than diet.
The team also used genetic interventions, pharmacological drugs, and nerve-targeting approaches. Each intervention aimed to disrupt the prostaglandin E2 pathway.
The findings suggest that blocking this signaling could be a therapeutic target. The study was conducted entirely in mice. That is a major caveat.
Human patients with Lkb1-mutant lung cancer may respond differently. But the work opens a new avenue for understanding why some cancer patients with certain genetic mutations respond poorly to dietary interventions.
Lkb1 is a tumor-suppressing gene. When mutated, it is known to drive aggressive lung cancers. The new data show it also drives cachexia — and that a high-fat diet, rather than countering the wasting, accelerates it.
The team compared tumors with different genetic alterations. Only those with Lkb1 mutations triggered the cachexia response. The high-fat diet did not cause cachexia in mice with other tumor types.
The effect was specific. What the numbers do not yet show is whether this pathway operates in humans.
That will require clinical studies. But the mouse data are clear: tumor genetics, diet, and the nervous system interact through prostaglandin E2 to produce cachexia. For now, the findings point to a potential therapeutic target.
No effective therapies exist for cachexia. The condition affects millions of cancer patients worldwide.
The numbers from this study offer a direction — one that could eventually lead to treatments that spare patients the devastating weight loss and muscle wasting that so often accompany advanced cancer.
{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “High-Fat Diet Worsens Wasting Syndrome in Mice with Lkb1 Mutation”, “description”: “CHICAGO — The numbers tell a grim story. In mice with lung tumors carrying a specific genetic flaw, a high-fat diet did not help. It…”, “datePublished”: “2026-07-02T15:57:00+00:00T09:30:00+00:00”, “author”: {“@type”: “Person”, “name”: “Isabella Moore”}, “publisher”: {“@type”: “Organization”, “name”: “InfoPulse Today”, “url”: “https://newsfeed.infopulsetoday.com/”}}
